BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38504608)

  • 21. A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy.
    Rah JE; Kim GY; Oh DH; Kim TH; Kim JW; Kim DY; Park SY; Shin D
    Radiat Oncol; 2016 Oct; 11(1):140. PubMed ID: 27769262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas.
    Gaito S; Abravan A; Richardson J; Lowe M; Indelicato DJ; Burnet N; Smith E
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):507-516. PubMed ID: 33820695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric comparison of three different treatment modalities for total scalp irradiation: the conventional lateral photon-electron technique, helical tomotherapy, and volumetric-modulated arc therapy.
    Song JH; Jung JY; Park HW; Lee GW; Chae SM; Kay CS; Son SH
    J Radiat Res; 2015 Jul; 56(4):717-26. PubMed ID: 24927727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing photon and proton-based hypofractioned SBRT for prostate cancer accounting for robustness and realistic treatment deliverability.
    Goddard LC; Brodin NP; Bodner WR; Garg MK; Tomé WA
    Br J Radiol; 2018 May; 91(1085):20180010. PubMed ID: 29436852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPY.
    Baues C; Marnitz S; Engert A; Baus W; Jablonska K; Fogliata A; Vásquez-Torres A; Scorsetti M; Cozzi L
    Radiat Oncol; 2018 Jul; 13(1):122. PubMed ID: 29970105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A treatment planning comparison between proton beam therapy and intensity-modulated x-ray therapy for recurrent nasopharyngeal carcinoma.
    Liu SW; Li JM; Chang JY; Yu JM; Chen Q; Jiang QA; Mu XK; Zhao MH; Tian Y; Wei QL
    J Xray Sci Technol; 2010; 18(4):443-50. PubMed ID: 21045280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What Can Proton Beam Therapy Achieve for Patients with Pectus Excavatum Requiring Left Breast, Axilla and Internal Mammary Nodal Radiotherapy?
    Settatree S; Dunlop A; Mohajer J; Brand D; Mooney L; Ross G; Gulliford S; Harris E; Kirby A
    Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e570-e577. PubMed ID: 34226114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective Planning Study of Patients with Superior Sulcus Tumours Comparing Pencil Beam Scanning Protons to Volumetric-Modulated Arc Therapy.
    Wong SL; Alshaikhi J; Grimes H; Amos RA; Poynter A; Rompokos V; Gulliford S; Royle G; Liao Z; Sharma RA; Mendes R
    Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):e118-e131. PubMed ID: 32798157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-ventricular irradiation for intracranial germ cell tumors: Dosimetric comparison of pencil beam scanned protons, intensity-modulated radiotherapy and volumetric-modulated arc therapy.
    Correia D; Terribilini D; Zepter S; Pica A; Bizzocchi N; Volken W; Stieb S; Ahlhelm F; Herrmann E; Fix MK; Manser P; Aebersold DM; Weber DC
    Clin Transl Radiat Oncol; 2019 Feb; 15():53-61. PubMed ID: 30734001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
    Franceschini D; Cozzi L; Fogliata A; Marini B; Di Cristina L; Dominici L; Spoto R; Franzese C; Navarria P; Comito T; Reggiori G; Tomatis S; Scorsetti M
    Radiat Oncol; 2022 Aug; 17(1):150. PubMed ID: 36028862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton Beam Therapy for Locally Advanced Head and Neck Tumors: An Analysis of Dosimetric and Clinical Outcomes.
    Sheikh S; Kharouta MZ; Pidikiti R; Damico NJ; Choi S; Dorth JA; Mansur DB; Machtay MX; Yao M; Bhatt AD
    Am J Clin Oncol; 2022 Feb; 45(2):81-87. PubMed ID: 35073281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.
    Stokkevåg CH; Indelicato DJ; Herfarth K; Magelssen H; Evensen ME; Ugland M; Nordberg T; Nystad TA; Hægeland C; Alsaker MD; Ulven K; Dale JE; Engeseth GM; Boer CG; Toussaint L; Kornerup JS; Pettersen HES; Brydøy M; Brandal P; Muren LP
    Acta Oncol; 2019 Oct; 58(10):1416-1422. PubMed ID: 31364899
    [No Abstract]   [Full Text] [Related]  

  • 34. Dosimetric comparison between proton beam therapy, intensity modulated radiation therapy, and 3D conformal therapy for soft tissue extremity sarcoma.
    Laughlin BS; Golafshar M; Prince M; Liu W; Kutyreff CJ; Ahmed SK; Vern Gross TZ; Haddock M; Petersen I; DeWees TA; Ashman JB
    Acta Oncol; 2023 May; 62(5):473-479. PubMed ID: 37154167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose and robustness comparison of nominal, daily and accumulated doses for photon and proton treatment of sinonasal cancer.
    Argota-Perez R; Sharma MB; Elstrøm UV; Møller DS; Grau C; Jensen K; Holm AIS; Korreman SS
    Radiother Oncol; 2022 Aug; 173():102-108. PubMed ID: 35667574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
    Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
    J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Range modulation in proton therapy planning: a simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams.
    Buchsbaum JC; McDonald MW; Johnstone PA; Hoene T; Mendonca M; Cheng CW; Das IJ; McMullen KP; Wolanski MR
    Radiat Oncol; 2014 Jan; 9():2. PubMed ID: 24383792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bringing FLASH to the Clinic: Treatment Planning Considerations for Ultrahigh Dose-Rate Proton Beams.
    van Marlen P; Dahele M; Folkerts M; Abel E; Slotman BJ; Verbakel WFAR
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):621-629. PubMed ID: 31759074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
    Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
    Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the Need for Adjusted Organ-at-Risk Planning Goals for Patients Undergoing Adjuvant Radiation Therapy for Locally Advanced Breast Cancer with Proton Radiation.
    DeCesaris CM; Pollock A; Zhang B; Poirier Y; Kowalski E; Paulosky K; Mishra MV; Nichols E
    Pract Radiat Oncol; 2021; 11(2):108-118. PubMed ID: 33109494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.